ArticleCancer research2020

Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer.

Josephine A Taverna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.